Company profile
MNDL Bio
The Predictive Engine for Scalable Protein Production
- Industry
- Biotechnology Research
- Employees
- 15
- Headquarters
- TEL AVIV
- Founded
- 2024
- Office locations
- 1
MNDL Bio company summary
MNDL Bio is a company in the Biotechnology Research industry, headquartered in TEL AVIV, founded in 2024. On LinkedIn the company has around 15 employees. Its listed specialties include biology, synthetic biology, bioengineering, gene expression, alternative protein.
What technology does MNDL Bio use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About MNDL Bio
MNDL Bio is building the predictive engine for scalable protein production. AI has accelerated protein discovery - but manufacturing remains one of biotech’s biggest bottlenecks. Companies still spend years in costly trial-and-error cycles trying to achieve stable, high-yield protein expression at industrial scale. We replace that uncertainty with software. Our AI-powered engineering engine combines mechanistic biophysical modeling with generative algorithms to design full genetic construct architecture - not just codon optimization. We engineer manufacturability at the DNA level, improving the probability of high, stable expression before expensive scale-up and CMC processes begin. Built on 15+ years of research led by our CSO, Prof. Tamir Tuller, our proprietary models form a defensible scientific core, strengthened by a growing real-world data flywheel. We work with biotech, biopharma, enzyme, and synthetic biology teams to: • Increase protein yield • Reduce development timelines • Lower scale-up risk • Improve production robustness MNDL Bio is a scalable software platform designed for enterprise deployment across global protein development pipelines. Predictable biology starts with engineered DNA.
Specialties
Where is MNDL Bio located?
MNDL Bio lists 1 location.
Compare companies similar to MNDL Bio
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
MNDL Bio mndl.bio | Biotechnology Research | 15 | 2024 | TEL AVIV |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about MNDL Bio
What does MNDL Bio do?
MNDL Bio is building the predictive engine for scalable protein production. AI has accelerated protein discovery - but manufacturing remains one of biotech’s biggest bottlenecks. Companies still spend years in costly trial-and-error cycles trying to achieve stable, high-yield protein expression at industrial scale. We replace that uncertainty with software. Our AI-powered engineering engine combines mechanistic biophysical modeling with generative algorithms to design full genetic construct architecture - not just codon optimization. We engineer manufacturability at the DNA level, improving the probability of high, stable expression before expensive scale-up and CMC processes begin. Built on 15+ years of research led by our CSO, Prof. Tamir Tuller, our proprietary models form a defensible scientific core, strengthened by a growing real-world data flywheel. We work with biotech, biopharma, enzyme, and synthetic biology teams to: • Increase protein yield • Reduce development timelines • Lower scale-up risk • Improve production robustness MNDL Bio is a scalable software platform designed for enterprise deployment across global protein development pipelines. Predictable biology starts with engineered DNA.
How many employees does MNDL Bio have?
MNDL Bio has around 15 employees on LinkedIn.
Where is MNDL Bio headquartered?
MNDL Bio is headquartered in TEL AVIV.
When was MNDL Bio founded?
MNDL Bio was founded in 2024.
Build a lead list from companies like MNDL Bio
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.